← All trials
NCT05358912
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 2, 2019
- Primary completion
- Sep 10, 2022
- Completion date
- Sep 21, 2022
- First posted
- May 3, 2022
- Last posted
- Nov 29, 2022
- Enrollment
- 85
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Izmir Bozyaka Training and Research HospitalLead sponsor
- Izmir Bozyaka Training and Research HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.